Cresteil T - Search Results

1

CYP2D6- and CYP3A-dependent metabolism of dextromethorphan in humans.

Jacqz-Aigrain E, Funck-Brentano C, Cresteil T. Jacqz-Aigrain E, et al. Among authors: cresteil t. Pharmacogenetics. 1993 Aug;3(4):197-204. doi: 10.1097/00008571-199308000-00004. Pharmacogenetics. 1993. PMID: 8220439

2

Phenotyping-genotyping of alternatively spliced genes in one step: study of CYP3A5*3 polymorphism.

Busi F, Cresteil T. Busi F, et al. Among authors: cresteil t. Pharmacogenet Genomics. 2005 Jun;15(6):433-9. doi: 10.1097/01213011-200506000-00010. Pharmacogenet Genomics. 2005. PMID: 15900218

3

In vitro metabolism study of buprenorphine: evidence for new metabolic pathways.

Picard N, Cresteil T, Djebli N, Marquet P. Picard N, et al. Among authors: cresteil t. Drug Metab Dispos. 2005 May;33(5):689-95. doi: 10.1124/dmd.105.003681. Epub 2005 Mar 2. Drug Metab Dispos. 2005. PMID: 15743975

4

Characterization of a phase 1 metabolite of mycophenolic acid produced by CYP3A4/5.

Picard N, Cresteil T, Prémaud A, Marquet P. Picard N, et al. Among authors: cresteil t. Ther Drug Monit. 2004 Dec;26(6):600-8. doi: 10.1097/00007691-200412000-00004. Ther Drug Monit. 2004. PMID: 15570183

5

Regioselective metabolism of taxoids by human CYP3A4 and 2C8: structure-activity relationship.

Cresteil T, Monsarrat B, Dubois J, Sonnier M, Alvinerie P, Gueritte F. Cresteil T, et al. Drug Metab Dispos. 2002 Apr;30(4):438-45. doi: 10.1124/dmd.30.4.438. Drug Metab Dispos. 2002. PMID: 11901098

6

Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humans.

Santos A, Zanetta S, Cresteil T, Deroussent A, Pein F, Raymond E, Vernillet L, Risse ML, Boige V, Gouyette A, Vassal G. Santos A, et al. Among authors: cresteil t. Clin Cancer Res. 2000 May;6(5):2012-20. Clin Cancer Res. 2000. PMID: 10815927 Clinical Trial.

7

Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites.

Marill J, Cresteil T, Lanotte M, Chabot GG. Marill J, et al. Among authors: cresteil t. Mol Pharmacol. 2000 Dec;58(6):1341-8. doi: 10.1124/mol.58.6.1341. Mol Pharmacol. 2000. PMID: 11093772

8

Oxidative metabolism of amprenavir in the human liver. Effect of the CYP3A maturation.

Tréluyer JM, Bowers G, Cazali N, Sonnier M, Rey E, Pons G, Cresteil T. Tréluyer JM, et al. Among authors: cresteil t. Drug Metab Dispos. 2003 Mar;31(3):275-81. doi: 10.1124/dmd.31.3.275. Drug Metab Dispos. 2003. PMID: 12584153

9

Evidence of impaired cisapride metabolism in neonates.

Tréluyer JM, Rey E, Sonnier M, Pons G, Cresteil T. Tréluyer JM, et al. Among authors: cresteil t. Br J Clin Pharmacol. 2001 Oct;52(4):419-25. doi: 10.1046/j.0306-5251.2001.01470.x. Br J Clin Pharmacol. 2001. PMID: 11678785 Free PMC article.

10

Biotransformation of taxoids by human cytochromes P450: structure-activity relationship.

Monsarrat B, Royer I, Wright M, Cresteil T. Monsarrat B, et al. Among authors: cresteil t. Bull Cancer. 1997 Feb;84(2):125-33. Bull Cancer. 1997. PMID: 9180834 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results